1
|
Sim I, O’neill L, Whitaker J, Mukherjee R, O’hare D, Fitzpatrick N, Niederer S, O’neill M, Shattock M, Williams S. Dynamic voltage attenuation identifies atrial fibrosis in a rabbit model: simultaneous assessment with optical mapping and contact electrogram mapping. Europace 2022. [DOI: 10.1093/europace/euac053.624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Foundation. Main funding source(s): British Heart Foundation. Academy of Medical Sciences.
Background
Bipolar voltage amplitude is a widely-used clinical parameter in atrial electrophysiology procedures. However, voltage amplitude is variable, and it has been shown that increasing activation rate decreases bipolar voltage amplitude in patients with atrial fibrillation. It is not known whether such voltage attenuation is a marker of the presence of atrial fibrosis which could therefore be used to improve intra-procedural assessment of atrial cardiomyopathy.
Purpose
We sought to investigate the effect of increasing activation rate on bipolar voltage amplitude in both healthy and fibrotic left atrial tissue.
Methods
10 New Zealand Rabbits were fed a high cholesterol diet (0.75%) for a period of 12 weeks to create an atrial fibrosis model. 10 Animals were fed normal chow. After terminal anaesthesia the heart was excised, and optical and voltage mapping of the excised left atrial tissue was performed. Blebbistatin was used to maintain cardiac stasis and the voltage sensitive dye RH237 was used for optical mapping. Voltage and optical recordings were made during pacing was from 3 different directions at rates from 2-6Hz and at 3 sites across the atrial tissue. Voltage amplitude was recorded as the mean amplitude over 10 beats during steady-state pacing. Optical recordings were used to measure conduction velocity and action potential characteristics. Only pacing runs showing 1:1 conduction were included in analysis. Atrial fibrosis was assessed using Masson’s Trichrome staining.
Results
The degree of atrial fibrosis was significantly greater in the atrial fibrosis model compared to healthy controls (15±3.24% vs. 9.74±4.98%, p=0.0069). Median voltage at base rate pacing of 2Hz was not significantly different between control and fibrotic atria (11.63mV, IQR 6.35mV vs. 10.3mV, IQR 6.81mV, p=0.71, respectively). Median voltage was significantly lower at 6Hz than at 2Hz in the control group (9.84mV, IQR 6.87mV, p=0.046). The degree of voltage attenuation between study groups was not significantly different between when pacing at 3hz or 4hz, whereas pacing at 5Hz and 6Hz showed significantly greater attenuation in fibrotic atria. At 5Hz the median reduction in amplitude from baseline in control vs fibrotic atria was 0.88mV, IQR 2.36mV vs 1.92mV, IQR 1.63mV (p=0.031). At 6 Hz the median reduction was 0.94mV, IQR 1.69mV vs 2.68mV, IQR 1.11mV, p=0.013 in control and fibrotic groups respectively.
Discussion
High cholesterol diet increased atrial fibrosis in a rabbit model. Bipolar voltage amplitude attenuation occurred in both control and fibrotic atria however the degree of voltage attenuation was significantly greater in fibrotic atria. These findings support the further evaluation of dynamic voltage attenuation for intraprocedural identification of atrial fibrosis.
Collapse
Affiliation(s)
- I Sim
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - L O’neill
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - J Whitaker
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - R Mukherjee
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - D O’hare
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - N Fitzpatrick
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - S Niederer
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - M O’neill
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - M Shattock
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - S Williams
- University of Edinburgh, Edinburgh, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
2
|
Sim I, Razeghi O, Solis Lemus JA, Mukherjee R, O’hare D, O’neill L, Kotadia I, Roney CH, Wright M, Chiribiri A, Niederer S, O’neill M, Williams SE. Atrial tissue characterisation using electroanatomic voltage mapping and cardiac magnetic resonance imaging. Europace 2022. [DOI: 10.1093/europace/euac053.177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Foundation. Main funding source(s): British Heart Foundation
Background
Atrial voltage mapping and atrial cardiac magnetic resonance imaging are two contemporary methods for quantification of atrial fibrosis. However, the absence of a gold standard for measuring atrial fibrosis has precluded their direct comparison. Nevertheless, understanding the relative performance of voltage mapping and atrial late gadolinium enhancement for identification of atrial cardiomyopathy remains critical to correctly targeting clinical application of these techniques.
Purpose
To assess the relative performance of electroanatomic voltage mapping and atrial late gadolinium enhancement imaging using three surrogate markers chosen to distinguish pre-procedural utility (progression to recurrent atrial fibrillation following ablation) from potential utility for providing atrial fibrillation mechanistic insights (paroxysmal vs. persistent status of atrial fibrillation and relationship with co-morbidities associated with atrial fibrillation).
Methods
123 patients underwent atrial late gadolinium enhancement imaging and electroanatomic voltage mapping prior to atrial fibrillation ablation. Atrial late gadolinium enhancement imaging was assessed with CEMRG software and electroanatomic voltage mapping processed with OpenEP software using previously published thresholds. Low voltage tissue was defined at (1) <0.5mV, (2) <1.17mV, and (3) <1.3mV. Atrial fibrosis using late gadolinium enhancement was defined using four thresholds (1) signal intensity >3.3 standard deviations above the blood pool mean; (2) image intensity ratio (IIR) 1.2x blood pool mean; (3) IIR 1.32x blood pool mean; and (4) IIR 0.97x blood pool mean.
Results
Patients with persistent atrial fibrillation and those with CHA2DS2VaSc >2 had increased low voltage area for each of the thresholds tested, but there was no increase in atrial late gadolinium enhancement area at any of the imaging thresholds tested.
Increased atrial fibrosis using IIR>0.97 was independently associated with recurrence of atrial fibrillation (OR 1.05 (CI 1.01-1.09), p=0.009) in both univariate and multivariate analysis. Low voltage area <1.13mV and low voltage area <1.17mV were associated with increased risk of recurrence (OR 1.02 (CI 1.01-1.04), p=0.01, and OR 1.03 (CI 1.01-1.04), p=0.009) in univariate analysis but neither voltage threshold remained statistically significant in multivariate analysis controlling for clinical variables.
Conclusion
Increased fibrosis burden measured with atrial magnetic resonance imaging, but not with low voltage area, is independently associated with recurrence of atrial fibrillation following catheter ablation. However, increased low voltage area measured with electroanatomic mapping is associated with persistent atrial fibrillation status and CHADS2VaSc score. These findings support the use of magnetic resonance imaging for pre-procedure assessment and the use of electroanatomic mapping for intraprocedural mechanism-based assessment of atrial cardiomyopathy.
Collapse
Affiliation(s)
- I Sim
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - O Razeghi
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - JA Solis Lemus
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - R Mukherjee
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - D O’hare
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - L O’neill
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - I Kotadia
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - CH Roney
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - M Wright
- St Thomas’ Hospital, Cardiology, London, United Kingdom of Great Britain & Northern Ireland
| | - A Chiribiri
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - S Niederer
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - M O’neill
- Kings College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - SE Williams
- University of Edinburgh, Edinburgh, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
3
|
Monaci S, Qian S, Gillette K, Mukherjee R, Haberland U, Elliott MK, Rajani R, Rinaldi CA, O’neill M, Plank G, King A, Bishop MJ. Non-invasive delineation of ventricular tachycardia substrates for cardiac stereotactic body radiotherapy: utility of in-silico pace-mapping. Europace 2022. [DOI: 10.1093/europace/euac053.342] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public Institution(s). Main funding source(s): EPSRC
Background
Cardiac stereotactive body radiotherapy (CSBRT) is an emerging, non-invasive ablation modality that targets ventricular tachycardia (VT) substrates in patients with limited conventional treatment options. Success of CSBRT hinges primarily on the correct identification of VT targets, which requires non-invasive planning. Current non-invasive, pre-procedure strategies employ multi-electrode electrocardiographic imaging (ECGi). Given its significant cost and potential challenges in detecting endocardial, intramural and/or septal VT sites, there is a need to optimise VT delineation strategies for CSBRT; patient-specific simulations may show promise at guiding such planning non-invasively.
Purpose
We aim to perform non-invasive, in-silico pace-mapping on an image-based computational model to identify VT substrates for CSBRT. We intend to show the utility of our fast computational pipeline - relying on CT imaging data only - to provide further insights on inaccessible, scar-related VT episodes.
Methods
A detailed computational torso model of a CSBRT candidate with incessant VT was generated from CT imaging data. Extracellular content volumes (ECVs) were used to identify different tissue types (healthy, border zone and non-conducting), and scale model tissue conductivities accordingly. In-silico pace-mapping was performed by simulating ~360 paced beats across the LV, and computing corresponding 12-lead ECGs within a fast electrophysiological (EP) simulation environment combining reaction-eikonal and lead field methods. QRS complexes from simulated paced beats were used to construct the virtual correlation pace-map against the measured QRS of the clinically-induced VT, along with a ‘reference-less’ virtual pace-map constructed from neighbouring paced-beat QRSs (within a 20 mm radius). An epicardial activation map of the clinically-induced VT was reconstructed from ECGi measurement, and used for comparison against our virtual pace-maps.
Results
Correlations between simulated paced-beat QRS complexes and the clinically-induced VT QRS were higher in mid-apical, infero-septal segments - segment 9 (85.71%), 10 (87.95%) and 15 (89.58%) - identifying septal origin and pathway of the induced re-entrant circuit. A possible septal VT isthmus was also identified by a high gradient in the virtual reference-less pace-map in segment 9 (> 2.5%/mm). Our in-silico predictions were in agreement with the clinical regions identified for CSBRT (segment 9 and 15), and provided additional information on the 3D and septal dynamics of the VT episode.
Conclusions
Our in-silico pace-mapping study successfully localised VT substrates in a patient unable to receive standard ablative procedures, and provided further clinical insight on the induced VT dynamics. Our rapid in-silico pace-mapping approach may be utilised to support optimal identification of VT target volumes for CSBRT.
Collapse
Affiliation(s)
- S Monaci
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - S Qian
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - K Gillette
- Medical University of Graz, Graz, Austria
| | - R Mukherjee
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - U Haberland
- Siemens Healthineers, London, United Kingdom of Great Britain & Northern Ireland
| | - MK Elliott
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - R Rajani
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - CA Rinaldi
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - M O’neill
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - G Plank
- Medical University of Graz, Graz, Austria
| | - A King
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - MJ Bishop
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
4
|
Campos F, Shiferaw Y, Whitaker J, O’neill M, Razavi R, Plank G, Bishop MJ. Subthreshold delayed afterdepolarizations mediated by reduced tissue conductivity form a substrate for unidirectional block and reentry within the infarcted heart. Europace 2022. [DOI: 10.1093/europace/euac053.602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Public grant(s) – National budget only. Main funding source(s): British Heart Foundation, Wellcome Trust
Background
Delayed afterdepolarizations (DADs) due to spontaneous calcium release (SCR) events at the subcellular scale have been associated with arrhythmia formation in the border zone (BZ) of infarcted hearts. DADs may not only summate to form ectopic focal sources but may also inactivate sodium channels forming a substrate for unidirectional conduction block and reentry. The role played by infarct anatomy and altered intracellular coupling in facilitating this phenomenon is not fully understood.
Purpose
To use computational modelling to investigate the role of anatomical properties of the infarct BZ in creating a substrate for DAD-mediated conduction block and reentry.
Methods
MRI data from a porcine post-infarction heart was used to build the computational model. A phenomenological model was used to simulate SCRs in the BZ. Arrhythmia susceptibility was quantified by pacing the model followed by a pause, to see whether DADs would occur, and an extra S2 beat with different coupling intervals (CIs). Tissue conductivity in the BZ was decreased to investigate the effect of uncoupling on DAD-mediated conduction block.
Results
Subthreshold DADs occurring within the infarct BZ inactivated the fast sodium channels which resulted in block of S2 beats. This occurred most readily in narrow isthmuses where electrotonic load was attenuated by the non-conducting scar. DADs rendered the entire isthmus area refractory establishing a substrate for unidirectional block and reentry (see Fig. A). Reduced tissue conductivity in the BZ reduced electrotonic load on cells undergoing DADs. This led to more local tissue depolarization (Vm) as uncoupling prevented current from flowing to neighboring cells at rest (Fig. B-C). Reduced tissue conductivity also enhanced DAD-mediated block by increasing the vulnerable window for reentry initiation (700ms < S2 CI < 900ms as shown in Fig. D).
Conclusion
Subthreshold DADs provide a substrate for arrhythmogenesis in the infarct BZ. Tissue uncoupling enhanced the arrhythmogenic risk by increasing the time window of unidirectional block.
Collapse
Affiliation(s)
- F Campos
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - Y Shiferaw
- University of California Los Angeles, Department of Physics, Los Angeles, United States of America
| | - J Whitaker
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - M O’neill
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - R Razavi
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| | - G Plank
- Medical University of Graz, Graz, Austria
| | - MJ Bishop
- King’s College London, London, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
5
|
Williams S, Roney CH, Connolly A, Smith P, Bishop M, Niederer S, Whitaker J, Corrado C, Kotadia I, O’hare D, Fitzpatrick N, Sim I, O’neill M. Interpolation of electrophysiology parameters using OpenEP: technology development and clinical application. Europace 2022. [DOI: 10.1093/europace/euac053.049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Foundation. Main funding source(s): British Heart Foundation
Background
Interpolation of data is common during clinical electrophysiology procedures. Applications include local activation mapping, voltage mapping and novel techniques including Sparkle and Coherence mapping. Nevertheless, underlying interpolation algorithms are proprietary and therefore challenging to reproduce. Importantly, direct comparison of electroanatomic datasets between system vendors is therefore not possible.
Purpose
We sought to (1) develop an open-source architecture for interpolation within the Open Electrophysiology Framework for Research (OpenEP; https://openep.io); (2) to provide three interpolation methods within this architecture and (3) to evaluate their performance against clinical data.
Method
The software architecture is shown in Figure 1A. The currently available methods are Radial Basis [1], Scattered Interpolant [2] and Local Smoothing [3]. Default parameters for each method are shown in Figure 1B.
The performance of each method was assessed using clinical left atrial mapping data, using the default options for each scheme. Following interpolation, a sample of 1000 activation/voltage points per mesh was used for analysis. For each interpolation method, correlation with clinical data was assessed using the intra-class correlation coefficient, whilst agreement was assessed using Bland Altman limits of agreement.
Results
For activation mapping, radial basis interpolation resulted in a smoother field than local smoothing, whilst scattered interpolation required more filtering of extreme values. Correlations between interpolated and original activation times were excellent for all interpolation schemes (radial basis R=0.91, p<0.0001; local smoothing R=0.95, p<0.0001; scattered interpolant R=0.92, p<0.0001). Local smoothing resulted in the narrowest 95 percent limits of agreement (-19 to +20ms), compared to radial basis (-24 to +28ms) and scattered interpolation (-22 to +25ms).
For voltage mapping, the interpolation schemes resulted in similar appearances of low voltage areas, however correlations with clinical data were weaker than for activation mapping (radial basis R=0.84, p<0.0001; local smoothing R=0.82, p<0.0001; scattered interpolant R=0.79, p<0.0001). The 95 percent limits of agreement were wide as a proportion of the mean data values, ranging from 83% (-0.8 to +0.66mV) for local smoothing to 97% (-0.78 to +0.63mV) for radial basis interpolation.
Conclusion
An extensible architecture is provided for data interpolation in OpenEP together with three interpolation methods. The methods performed wellfor local activation time interpolation but variation compared to clinical data was greater for voltage mapping. This new architecture will permit the optimisation of interpolation methods against "gold standard" simulation or histological data and facilitate comparison of datasets between system vendors.
Collapse
Affiliation(s)
- S Williams
- University of Edinburgh, Edinburgh, United Kingdom of Great Britain & Northern Ireland
| | - CH Roney
- Queen Mary University of London, London, United Kingdom of Great Britain & Northern Ireland
| | - A Connolly
- King’s College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - P Smith
- King’s College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - M Bishop
- King’s College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - S Niederer
- King’s College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - J Whitaker
- King’s College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - C Corrado
- King’s College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - I Kotadia
- King’s College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - D O’hare
- King’s College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - N Fitzpatrick
- King’s College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - I Sim
- King’s College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| | - M O’neill
- King’s College London, Biomedical Engineering and Imaging Sciences, London, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|